Abstract

New World Nonhuman Primates are highly susceptible to clinical toxoplasmosis. Serum samples from 126 recently captured Leontopithecus chrysomelas, from an exotic and invasive population, were tested for Toxoplasma gondii antibodies by the modified agglutination test (MAT, cut-off 1:25); all were seronegative. The MAT is highly specific and is not species-specific. This is the first report of T. gondii survey in this tamarin in the wild. This result is consistent with prior reports that showed the high susceptibility of the species to infection by T. gondii usually with high mortality rates.

Highlights

  • New World Nonhuman Primates are highly susceptible to clinical toxoplasmosis

  • Due to the risk of hybridization with local and endangered Leontopithecus rosalia (KIERULFF et al, 2008b), environmental authorities proposed the removal of the Golden-Headed Lion Tamarin (GHLT) population

  • New World Monkey (NWM) are considered highly susceptible whereas the Old World Monkeys are resistant to clinical toxoplasmosis, worldwide reports of T. gondii infection in monkeys have been described (DUBEY & BEATTIE, 1988; CATÃO-DIAS et al, 2013; DUBEY, 2010)

Read more

Summary

Introduction

New World Nonhuman Primates are highly susceptible to clinical toxoplasmosis. Serum samples from 126 recently captured Leontopithecus chrysomelas, from an exotic and invasive population, were tested for Toxoplasma gondii antibodies by the modified agglutination test (MAT, cut-off 1:25); all were seronegative. The Niterói area is fragmented and the GHLT population had been in close contact with humans and domestic animals. NWMs are considered highly susceptible whereas the Old World Monkeys are resistant to clinical toxoplasmosis, worldwide reports of T. gondii infection in monkeys have been described (DUBEY & BEATTIE, 1988; CATÃO-DIAS et al, 2013; DUBEY, 2010).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call